Debunking the Chemical Imbalance Myth in Depression Treatment

This chapter critically examines the prevailing notion that depression is solely a result of a chemical imbalance in the brain, proposing it as a myth perpetuated by the pharmaceutical industry. It highlights research questioning the efficacy of antidepressants and addresses ethical concerns regarding clinical trial transparency in the psychiatric field.